Action of certain antiprotozoal compounds against Babesia gibsoni in dogs.
D000284:Administration, Oral; D000578:Amidines / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D001391:Azo Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D001404:Babesiosis / Q000188:drug therapy* / Q000382:microbiology; D001549:Benzamides / Q000008:administration & dosage / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy* / Q000382:microbiology; D004285:Dogs; D006400:Hematocrit; D007273:Injections, Intramuscular; D009560:Niridazole / Q000008:administration & dosage / Q000627:therapeutic use; D010636:Phenols / Q000008:administration & dosage / Q000627:therapeutic use; D011803:Quinine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000578:Amidines; D000981:Antiprotozoal Agents; D001391:Azo Compounds; D001549:Benzamides; D010636:Phenols; D011803:Quinine; D009560:Niridazole